Related Experiment Videos
The changing face of infective endocarditis
1Department of Cardiology, Wythenshawe Hospital, Manchester, UK. bernard.prendergast@smuht.nwest.nhs.uk
Heart (British Cardiac Society)
|October 12, 2005
Summary
Infective endocarditis (IE) remains a serious heart infection with high mortality despite medical advances. Risk factors are shifting towards degenerative valve disease and intravenous drug use, impacting treatment strategies.
Area of Science:
- Cardiology
- Infectious Diseases
- Internal Medicine
Background:
- Infective endocarditis (IE) presents persistent high mortality and morbidity despite modern medical and surgical advancements.
- The incidence of IE has remained stable or increased over the last 20 years, indicating evolving epidemiology.
- Traditional risk factors like rheumatic heart disease are declining, replaced by degenerative valve disease, mitral valve prolapse, and intravenous drug misuse.
Purpose of the Study:
- To review the current understanding of infective endocarditis.
- To update recent developments in the medical and surgical management of IE.
Main Methods:
- Literature review of infective endocarditis.
- Analysis of epidemiological trends and risk factor evolution.
- Synthesis of current medical and surgical treatment strategies.
Main Results:
- The epidemiology of IE is changing, with increasing prevalence in the elderly and intravenous drug users.
- Staphylococcal infections and those caused by fastidious organisms are becoming more common.
- Despite advances, IE continues to pose significant challenges in diagnosis and treatment.
Conclusions:
- Infective endocarditis requires ongoing research and adaptation of management strategies due to its evolving nature and persistent risks.
- Understanding the shift in risk factors is crucial for effective prevention and treatment of IE.
- Multidisciplinary approaches integrating medical and surgical interventions are essential for improving outcomes in IE patients.